-
Nature Communications Study from The Lundquist Institute Identifies Molecular Mechanism Underlying Peripartum Cardiomyopathy
Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that protects the heart during pregnancy, shedding new light on the causes of…
Research -
Dr. Rajesh K. Garg Recognized for Key Contributions to the 2026 ADA Standards of Care in Diabetes
The American Diabetes Association (ADA) has formally recognized Dr. Rajesh K. Garg, MD, for his important contributions to the 2026 ADA Standards of Care in Diabetes, one of…
Research -
The Lundquist Institute proudly welcomes Dr. Michelle L. Matter
Michelle L. Matter, PhD joins The Lundquist Institute as an expert in two areas of cardiovascular medicine: cardiomyopathies and sepsis. Underlying these two diseases is a common mechanism that involves cell adhesion…
Research -
We are delighted to welcome Dr. Santosh Kesari to The Lundquist Institute
Santosh Kesari, MD, PhD joins The Lundquist Institute as an esteemed investigator in Cancer Biology and Immunotherapeutics, bringing exceptional expertise as a board-certified neurologist, oncologist, and clinical trialist. His multidisciplinary research…
Research -
Are Food Additives Affecting Our Metabolism? Dr. Rajesh Garg’s Research Offers Important Clues
Every day, most of us eat foods that were made to last: breads, tortillas, yogurts, cheeses, lunch meats with preservatives, ingredients added to keep them safe, stable, and appealing. But what if some…
Research -
Reframing HIV Prevention Through Community, Trust, and Equity
Every December, HIV Awareness Month urges us not only to reflect on medical breakthroughs, but also to confront the inequities that endure despite them. Modern antiretroviral…
Community, Research -
The Lundquist Institute’s Medical-Financial Partnership Awarded $3.42M from the Conrad N. Hilton Foundation to Expand Innovative Health and Financial Care Model
The Lundquist Institute is proud to announce that its Medical-Financial Partnership (MFP), co-directed by Monique Holguin, LCSW, PhD, and Adam Schickedanz, MD, PhD, has been awarded…
Community, Research -
The Lundquist Institute and Its Start-Up Company Vitalex Biosciences Announce Strategic Advancement of Second-Generation Fungal Vaccine VXV-01 Through Phase 1 Trials Under $40 Million Competitive Contract From NIH/NIAID
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV01, which was…
Research -
Honoring Discovery and Dedication: Legends 2025 Celebrates Innovation at The Lundquist Institute
The Lundquist Institute’s annual Legends celebration brought together a full house of faculty, partners, and friends for an inspiring evening dedicated to the power of science, collaboration, and…
Leadership, Research -
Dr. Loren Miller presents oral late breaker at IDWeek 2025 of a first-of-its-kind clinical trial that shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia
During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented landmark findings from the Phase 2a diSArm study.…
Research